Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ming Bai, Zhi-Guo Li & Yi Ba. (2021) Influence of KDR Genetic Variation on the Efficacy and Safety of Patients with Chemotherapy Refractory Metastatic CRC Who Received Apatinib Treatment. International Journal of General Medicine 14, pages 1041-1055.
Read now
Read now
Pilar García-Alfonso, Gabriela Torres, Gonzalo García, Iria Gallego, Laura Ortega, Carmen Sandoval, Andrés Muñoz & Ariadna Lloansí. (2019) FOLFOXIRI plus biologics in advanced colorectal cancer. Expert Opinion on Biological Therapy 19:5, pages 411-422.
Read now
Read now
Articles from other publishers (27)
Pei-Chun Shih, Hsin-Pao Chen, Ching-Cheng Hsu, Chung-Hsien Lin, Chou-Yuan Ko, Chao-Wen Hsueh, Cheng-Yi Huang, Tian-Huei Chu, Cheng-Chun Wu, Yu-Cheng Ho, Ngoc Uyen Nhi Nguyen, Shih-Chung Huang, Cheng-Chieh Fang, Shiow-Jyu Tzou, Yueh-Jung Wu, Tung-Yuan Chen, Chuan-Fa Chang & Yung-Kuo Lee. (2023) Long-term DEHP/MEHP exposure promotes colorectal cancer stemness associated with glycosylation alterations. Environmental Pollution 327, pages 121476.
Crossref
Crossref
Anna Radajewska, Helena Moreira, Dorota Bęben, Oliwia Siwiela, Anna Szyjka, Katarzyna Gębczak, Paulina Nowak, Jakub Frąszczak, Fathi Emhemmed, Christian D. Muller & Ewa Barg. (2023) Combination of Irinotecan and Melatonin with the Natural Compounds Wogonin and Celastrol for Colon Cancer Treatment. International Journal of Molecular Sciences 24:11, pages 9544.
Crossref
Crossref
Cheng-Chin Lee, Ai-Wei Lee, Po-Li Wei, Yi-Shin Liu, Yu-Jia Chang & Chien-Yu Huang. (2023) In silico analysis to identify miR-1271-5p/PLCB4 (phospholipase C Beta 4) axis mediated oxaliplatin resistance in metastatic colorectal cancer. Scientific Reports 13:1.
Crossref
Crossref
Yu-Ling Qu, Xiao-Li Liu, Shan-Yu Zhao & Xue-Feng Zhai. (2022) SPOCK1 silencing decreases 5-FU resistance through PRRX1 in colorectal cancer. Pathology - Research and Practice 234, pages 153895.
Crossref
Crossref
Fakhria Al-Joufi, Aseem Setia, Mounir Salem-Bekhit, Ram Sahu, Fulwah Alqahtani, Retno Widyowati & Fadilah Aleanizy. (2022) Molecular Pathogenesis of Colorectal Cancer with an Emphasis on Recent Advances in Biomarkers, as Well as Nanotechnology-Based Diagnostic and Therapeutic Approaches. Nanomaterials 12:1, pages 169.
Crossref
Crossref
Jiahui Yuan, Xiaomei Li, Yuqi Zhang, Gongye Zhang, Weipeng Cheng, Weiwei Wang, Yongbin Lei & Gang Song. (2021) USP39 attenuates the antitumor activity of cisplatin on colon cancer cells dependent on p53. Cell Biology and Toxicology.
Crossref
Crossref
Xiao-Lan Qian, Fang Zhou, Song Xu, Jian Jiang, Zhi-Peng Chen, Shao-Kai Wang, Yun Zuo & Chen Ni. (2021) MiR-454-3p Promotes Oxaliplatin Resistance by Targeting PTEN in Colorectal Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Archana Katoch, Debasis Nayak, Mir Mohd. Faheem, Aviral Kumar, Promod Kumar Sahu, Ajai Prakash Gupta, Lekha Dinesh Kumar & Anindya Goswami. (2021) Natural podophyllotoxin analog 4DPG attenuates EMT and colorectal cancer progression via activation of checkpoint kinase 2. Cell Death Discovery 7:1.
Crossref
Crossref
Elena De Mattia, Alessia Bignucolo, Giuseppe Toffoli & Erika Cecchin. (2020) Genetic Markers of the Host to Predict the Efficacy of Colorectal Cancer Targeted Therapy. Current Medicinal Chemistry 27:25, pages 4249-4273.
Crossref
Crossref
Guan-Li Su, Yuan-Yuan Wang, Jin-Cheng Wang & Hao Liu. (2020) A meta-analysis comparing regorafenib with TAS-102 for treating refractory metastatic colorectal cancer. Journal of International Medical Research 48:7, pages 030006052092640.
Crossref
Crossref
Jong-Hee Ko, Hyuk-Sang Kwon, Bomin Kim, Gihong Min, Chorong Shin, Seok-Woo Yang, Seong Wook Lee, Youngmin Lee, Dahae Hong & Yong-Sung Kim. (2020) Preclinical Efficacy and Safety of an Anti-Human VEGFA and Anti-Human NRP1 Dual-Targeting Bispecific Antibody (IDB0076). Biomolecules 10:6, pages 919.
Crossref
Crossref
Mona Elsafadi, Muthurangan Manikandan, Sami Almalki, Amer Mahmood, Tasneem Shinwari, Radhakrishnan Vishnubalaji, Mohammad Mobarak, Musaad Alfayez, Abdullah Aldahmash, Moustapha Kassem & Nehad M. Alajez. (2020) Transgelin is a poor prognostic factor associated with advanced colorectal cancer (CRC) stage promoting tumor growth and migration in a TGFβ-dependent manner. Cell Death & Disease 11:5.
Crossref
Crossref
Qiongna Dong, Bizhi Shi, Min Zhou, Huiping Gao, Xiaoying Luo, Zonghai Li & Hua Jiang. (2019) Growth suppression of colorectal cancer expressing S492R EGFR by monoclonal antibody CH12. Frontiers of Medicine 13:1, pages 83-93.
Crossref
Crossref
Rui Wang, Rajat Bhattacharya, Xiangcang Ye, Fan Fan, Delphine R. Boulbes & Lee M. Ellis. (2019) Endothelial Cells Promote Colorectal Cancer Cell Survival by Activating the HER3-AKT Pathway in a Paracrine Fashion. Molecular Cancer Research 17:1, pages 20-29.
Crossref
Crossref
Dongdong Sun, Feng Zhang, Jie Qian, Weixing Shen, Huisen Fan, Jiani Tan, Liu Li, Changliang Xu, Ye Yang & Haibo Cheng. (2018) 4′-hydroxywogonin inhibits colorectal cancer angiogenesis by disrupting PI3K/AKT signaling. Chemico-Biological Interactions 296, pages 26-33.
Crossref
Crossref
Ana B.K. Abrahao, Yoo-Joung Ko, Scott Berry & Kelvin K.W. Chan. (2018) A Comparison of Regorafenib and TAS-102 for Metastatic Colorectal Cancer: A Systematic Review and Network Meta-analysis. Clinical Colorectal Cancer 17:2, pages 113-120.
Crossref
Crossref
Chunhong Zhang, Yangjie Xu, Haowen Wang, Gang Li, Han Yan, Zhenghua Fei, Yunsheng Xu & Wenfeng Li. (2018) Curcumin reverses irinotecan resistance in colon cancer cell by regulation of epithelial–mesenchymal transition. Anti-Cancer Drugs 29:4, pages 334-340.
Crossref
Crossref
Sajida Ibrahim, Alban Girault, Marc Ohresser, Emilie Lereclus, Gilles Paintaud, Thierry Lecomte & William Raoul. (2018) Monoclonal Antibodies Targeting the IL-17/IL-17RA Axis: An Opportunity to Improve the Efficiency of Anti-VEGF Therapy in Fighting Metastatic Colorectal Cancer?. Clinical Colorectal Cancer 17:1, pages e109-e113.
Crossref
Crossref
Haogang Zhang, Yaguang Zong, Gongcai Qiu, Ruichun Jia, Xunzheng Xu, Fujing Wang & Dequan Wu. (2018) Silencing Lin28 promotes apoptosis in colorectal cancer cells by upregulating let‑7c targeting of antiapoptotic BCL2L1. Molecular Medicine Reports.
Crossref
Crossref
Vincenzo Formica, Maria Teresa Ionta, Bruno Massidda, Giacomo Vessia, Luigi Maiorino, Rossana Casaretti, Donato Natale, Giuseppe Barberis, Gianfranco Filippelli, Ettore Greco, Livio Blasi, Sergio Mancarella, Anna Russo, Enrico Barbato, Liberato Di Lullo & Mario Roselli. (2017)
Predictive factors for 6
vs
12 cycles of Folfiri-Bevacizumab in metastatic colorectal cancer
. Oncotarget 9:2, pages 2876-2886.
Crossref
Crossref
V. V. Golotiuk. (2018) PROSPECTS OF APPLICATION OF PECTIN MODIFICATIONS IN THE COMPLEX MEDICAMENT THERAPY OF COLORECTAL CANCER. Bulletin of Problems Biology and Medicine 1.1:142, pages 25.
Crossref
Crossref
Toshikazu Moriwaki, Shota Fukuoka, Hiroya Taniguchi, Atsuo Takashima, Yusuke Kumekawa, Takeshi Kajiwara, Kentaro Yamazaki, Taito Esaki, Chinatsu Makiyama, Tadamichi Denda, Hironaga Satake, Takeshi Suto, Naotoshi Sugimoto, Masanobu Enomoto, Toshiaki Ishikawa, Tomomi Kashiwada, Masahiko Sugiyama, Yoshito Komatsu, Hiroyuki Okuyama, Eishi Baba, Daisuke Sakai, Tomoki Watanabe, Takao Tamura, Kimihiro Yamashita, Masahiko Gosho & Yasuhiro Shimada. (2018) Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study. The Oncologist 23:1, pages 7-15.
Crossref
Crossref
Xin-lin Chen, Zhuo-qun Chen, Shui-lian Zhu, Tian-wen Liu, Yi Wen, Yi-sheng Su, Xu-jie Xi, Yue Hu, Lei Lian & Feng-bin Liu. (2017) Prognostic value of transforming growth factor-beta in patients with colorectal cancer who undergo surgery: a meta-analysis. BMC Cancer 17:1.
Crossref
Crossref
Shao-Long Lu, Zhi-Hua Ye, Tong Ling, Si-Yuan Liang, Hui Li, Xiao-Zhun Tang, Yan-Song Xu & Wei-Zhong Tang. (2017) High pretreatment plasma D-dimer predicts poor survival of colorectal cancer: insight from a meta-analysis of observational studies. Oncotarget 8:46, pages 81186-81194.
Crossref
Crossref
Yong Yang, Guoxin Wang, Dajian Zhu, Yanfeng Huang, Yong Luo, Pengfei Su, Xiaowu Chen & Qian Wang. (2017) Epithelial-mesenchymal transition and cancer stem cell-like phenotype induced by Twist1 contribute to acquired resistance to irinotecan in colon cancer. International Journal of Oncology 51:2, pages 515-524.
Crossref
Crossref
Rui Wang, Rajat Bhattacharya, Xiangcang Ye, Fan Fan, Delphine R. Boulbes, Ling Xia & Lee M. Ellis. (2017)
Endothelial cells activate the cancer stem cell-associated
NANOGP8
pathway in colorectal cancer cells in a paracrine fashion
. Molecular Oncology 11:8, pages 1023-1034.
Crossref
Crossref
Alessia Bignucolo, Elena De Mattia, Erika Cecchin, Rossana Roncato & Giuseppe Toffoli. (2017) Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment. International Journal of Molecular Sciences 18:7, pages 1522.
Crossref
Crossref